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1. Introduction 
The future of mental health care will be both daunting in its challenges and filled with the 
promise of new and better ways of understanding, preventing and treating serious mental 
illness. Novel approaches for assessing and treating mental illness are being shaped by 
advances in neuroscience, genetics and the scientific validation of ancient healing 
traditions in the social context of a growing range of expert resources and services that are 
becoming possible through rapidly increasing global access to the internet. Future models 
of mental health care will be determined by demographic trends and economic necessity 
as well as changing social norms and increasingly holistic values among both physicians 
and patients.  
In the coming decades advances in conventional biomedicine will take in place in parallel 
with growing insight into the mechanisms underlying non-conventional therapies. 
Complementary and alternative medicine will evolve from the use of “herbs and vitamins” 
to a sophisticated research-driven model of integrative medicine based on individualized 
treatments incorporating biological, mind-body, informational and   energy therapies 
targeting complex multi-factoral causes of mental illness. Improvements in the 
pharmacological management of mental illness and advances in manufacturing and quality 
assurance of vitamins, herbals, amino acids and other natural products will result in more 
efficacious and safer conventional and alternative treatment choices for psychiatric 
disorders. Treatment protocols incorporating validated mind-body and energy therapies 
will become widely used preventive therapies for maintaining optimal mental functioning 
in healthy populations and will be more frequently “prescribed” for the treatment of 
depression, anxiety, psychosis and other mental health problems.  
Following a brief overview of the perspectives and limitations of biomedical psychiatry, 
emerging paradigms in the basic sciences and medicine that are changing the way we think 
about and treat mental illness are concisely described. Important recent research advances 
that will impact mental health care in the coming decades are summarized. Core principles 
and practical clinical methods of an emerging paradigm, integrative mental health care, are 
then discussed. In the coming decades advances in the basic sciences will transform 
biomedicine into a more robust and more complete paradigm that will reconcile modern 
Western scientific theory with the World’s great healing traditions. A near term benefit will 
be more effective person-centered mental health care. The emerging paradigm of integrative 
mental health care is an important step in this evolutionary process. The chapter concludes 
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with a forecast of important advances that will transform mental health care in the first 
decades of the 21st century.  
2. Framing the problem 
Conventional biomedicine—also called allopathic medicine—is based on an enormous body of 
research and is often very effective however conventional biomedicine has failed to adequately 
address medical and psychiatric illnesses in the United States and the world at large. In the 
U.S. 15% of the GNP (approximately $1.6 trillion) is spent on healthcare, yet drug reactions, 
infections, surgical errors or other complications of conventional medical care are among the 
leading causes of death and morbidity (Starfield 2000; Zhan 2003). Broad economic issues that 
interfere with the capacity of allopathic medicine, including the specialty branch called 
biomedical psychiatry, to meet health care needs include restrictions of treatments covered 
under managed care, Medicare, and private insurance contracts, growing dissatisfaction with 
the quality of conventional medical care because of concerns over efficacy and safety, and the 
increasing cost of care for the average consumer (Astin 1998a). 
The shortcomings of conventional treatments suggest that biomedicine does not fully 
explain the causes of mental illness while inviting rigorous consideration of novel 
explanatory models of symptom formation and studies on promising non-conventional 
treatment modalities. Growing acceptance of non-allopathic healing traditions in Western 
culture is the result of both scientific advances and social trends. Conventional biomedicine 
is being influenced by the increasing openness of Western culture to non-Western healing 
traditions in the context of growing demands for more meaningful and more personal 
contact with medical practitioners—often difficult to find during brief appointments in 
managed care settings. These issues have led increasing numbers of individuals who see 
conventionally trained physicians to seek concurrent treatment from alternative 
practitioners, including Chinese medical practitioners, herbalists, homeopathic physicians, 
energy healers and others (Barnes 2008).  
Recent years have witnessed growing openness to non-conventional therapies among 
conventionally trained clinicians and researchers. At the same time people who are critical of 
Western biomedicine as currently practiced are turning increasingly to non-conventional 
therapies for the treatment of both medical and mental health problems (Rees 2001; Astin 
1998a). Approximately 72 million U.S. adults used a non-conventional treatment in 2002, 
representing about one in three adults (Tindle 2005). If prayer is included in this analysis 
almost two thirds of adults use non-conventional therapies (Barnes & Bloom 2008). Anyone 
diagnosed with a psychiatric disorder is significantly more likely to use non-conventional 
therapies compared to the general population (Unutzer 2000; Unutzer 2002). One third of 
individuals who report a history of generalized anxiety, mood swings or psychotic symptoms 
use non-conventional approaches to treat their symptoms (Unutzer 2000). Furthermore, two 
thirds of severely depressed or acutely anxious individuals use both conventional and non-
conventional treatments concurrently, and as many as 90% of these see a psychiatrist or other 
mental health professional (Kessler 2001). The findings of two large patient surveys suggest 
that most individuals who have mental health problems use conventional medications and 
non-conventional approaches at the same time (Unutzer 2000; Eisenberg 1998). According to 
one large physician survey approximately half of U.S. physicians believe that acupuncture, 
chiropractic and homeopathy rest on valid medical principles, and frequently refer patients to 
non-conventional practitioners for these therapies (Astin 1998b).  
www.intechopen.com
 
The Future of Mental Health Care 455 
Mental health care in its present form is at a critical juncture. In spite of enormous industry-
funded research efforts over many decades the evidence supporting pharmacologic 
treatments of major psychiatric disorders is inconsistent and disappointing (Sussman 2004). 
Billions of dollars of research spending for new drug development have failed to 
significantly reduce the prevalence rates of serious psychiatric disorders. In fact there is 
evidence that rates of some disorders are increasing in spite of ongoing advances in 
biomedical psychiatry.  Furthermore, recently published systematic reviews of quality 
double-blind placebo-controlled trials fail to show strong efficacy for widely used 
conventional pharmacological therapies used to treat common psychiatric disorders 
including major depressive disorder, bipolar disorder, schizophrenia, dementia, and others  
(Moller 2007; Kirsch 2008; Thase 2008; Fournier et al 2010; Fountoulakis 2008; Katzman 2009; 
Dixon et al 2009; Tajima et al 2009; Birks 2006) In addition to growing concerns about their 
lack of efficacy psychopharmacologic treatments are plagued by serious safety issues. Many 
widely used psychotropic drugs are associated with serious adverse effects including 
weight gain and increased risk of diabetes and heart disease, neurologic disorders, and 
sudden cardiac death, and increased suicide risk. Furthermore conventional drugs often 
result in partial response or no response even when recommended treatment protocols are 
followed. The persistence of serious symptoms of mental illness during treatment results in 
impairments in occupational functioning with associated losses in productivity. Concerns 
about the limitations of contemporary biomedical psychiatry including inequalities in 
delivery of mental health services, the lack of integration of mental health services into other 
medical specialties, conflicts of interest in relationships with the pharmaceutical industry 
and other clinical practice issues have been raised by leading figures in academic psychiatry 
(Reynolds et al 2009).  
In response to the limitations of conventional mental health care future directions of research 
and clinical therapeutics are becoming progressively more open to the rigorous examination of 
novel perspectives. This growing intellectual openness is giving birth to a truly integrative 
model of mental health care that draws from the best evidence in both conventional 
biomedical psychiatry and alternative modalities. Novel theories are being advanced in 
response to the conceptual and practical clinical limitations of the orthodox view embraced by 
conventional biomedical psychiatry in efforts to more adequately explain both normal 
conscious functioning and the complex factors that contribute to mental illness. These 
emerging theories will shape the future of mental health care. They are at the heart of a rapidly 
evolving paradigm called “integrative mental health care” that is leading to innovative new 
research methods and more effective clinical therapeutics. At the level of individual patients 
an important result of this evolutionary process will be more effective and more compassionate 
“whole person” mental health care that takes into account the complex biological, 
psychological, social, cultural and possibly also spiritual causes and meanings of mental illness. 
3. Biomedicine and biomedical psychiatry in overview 
At its core, biomedicine or “allopathic” medicine incorporates assumptions about the nature 
of material existence and identifiable causal relationships between factors in the 
environment and illness phenomena that can be traced to cultural and philosophical roots of 
early Western civilization. This ancient philosophical perspective eventually led to the 
establishment of formal methods of observation and measurement, culminating in modern 
scientific method. In spite of the recent confirmation of a role of quantum mechanics in 
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complex living systems including the human brain, biomedicine continues to rely 
exclusively on the tenets of classical Newtonian physics in building its theories and 
evaluating claims of mechanism and demonstrations of outcomes in its clinical methods. In 
short, the dominant paradigm of contemporary biomedicine—and by extension biomedical 
psychiatry—rests on metaphysical assumptions about the properties of phenomena that can 
have existence according to the classical materialist world-view of the universe—a model 
that was replaced over a century ago by a more inclusive paradigm informed by quantum 
mechanics and general relativity theory.  
Contemporary biomedical psychiatry—the orthodox perspective in which mental health 
care is practiced—is based on the assumption that mind is a manifestation of what the brain 
does. Diverse perspectives on the so-called “mind-body” problem exist in contemporary 
psychiatry however there is still no consensus on a sufficient explanatory model of mind-
body interactions (Kendler 2001; Wright & Potter 2003). Complete understanding of mind-
body interactions will probably require a convergence of classical and non-classical 
paradigms (Shang 2001). For example, light exposure therapy is known to have therapeutic 
effects on melatonin and neurotransmitter activity and may also interact with brain 
dynamics on subtle levels possibly consistent with the postulates of quantum mechanics or 
quantum brain dynamics (Curtis 2004). The human bio-field is probably best described with 
respect to complex interactions between classical and non-classical kinds of energy and 
information, including electrical, magnetic, acoustic, and large-scale quantum properties of 
living systems (Rein 2004). Practitioners of conventional biomedicine frequently regard 
“energy” treatments as examples of the placebo effect because of the assumption that 
postulated forms of energy or information on which energy treatments rest simply do not 
exist. Rigorous research designs investigating “energy” medicine are difficult to achieve and 
findings on the effectiveness of directed intention and putative non-classical energy effects 
on human health remain inconclusive (Abbott 2000). Nevertheless, accumulating research 
evidence shows that beneficial effects of some energy treatments can be replicated under 
controlled conditions, suggesting that non-classical forms of energy or information influence 
outcomes in some cases. 
The reductionist perspective implicit in Western science informs the central dogma of 
biomedical psychiatry, namely neurotransmitter theory, which holds that discrete 
correspondences exist between symptoms of mental illness and deficiencies or dysfunction at 
the level of specific neurotransmitters (Lopez-Munoz 2009). To date the neurotransmitter 
theory has failed to provide an adequate explanatory model of the causes of mental illness 
or to consistently predict responses to treatments targeting specific neurotransmitters 
(Lopez-Munoz 2009). In addition to problems related to the questionable validity of core 
assumptions on which biomedical psychiatry is based, the orthodox paradigm is limited by 
numerous practical issues. Biomedical psychiatry prioritizes pharmacological and 
psychotherapeutic treatment of acute symptoms of serious chronic mental illnesses over 
prevention and maintaining wellness. While pharmacological treatments often result in 
rapid, dramatic stabilization of severe symptoms, many so-called maintenance therapies of 
common psychiatric disorders have marginal efficacy compared to placebos (Sussman 2004). 
Furthermore, significant unresolved safety issues and the high cost of many psychotropic 
drugs significantly limit the potential reach of biomedical psychiatry in Western culture and 
render them inaccessible and often irrelevant in less developed world regions. On a practical 
vein mental health care as practiced in North America, and the EU is typically limited to 
brief impersonal appointments emphasizing “medication management” under cost 
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constraints of “managed care” that fail to take into account the complex medical, 
psychosocial, cultural or spiritual factors that frequently contribute to mental illness.  
4. Biomedical psychiatry is an evolving paradigm 
Recent discoveries in neuroscience and genetics suggest that contemporary models of human 
consciousness and, by extension, understandings of mental illness are incomplete. Theories 
describing neurochemical mechanisms underlying normal brain functioning continue to 
evolve at a rapid rate pointing to the limitations of the neurotransmitter theory. This still-
current model advanced in the early 1960s characterizes neurotransmitters as substances that 
are invariably synthesized and released by neurons, act on post-synaptic receptors, and 
mediate both normal and abnormal states of consciousness in relationship to specific activity 
levels or dysregulations at the level of their synthesis or receptor binding affinities. In contrast 
to the above model in which dysregulations of specific neurotransmitters correspond to 
discrete symptoms, certain recently characterized neurotransmitters and neuropeptides are 
not stored in synaptic vesicles or released by exocytosis and do not act at receptor sites on 
post-synaptic vesicles, thus they do not fulfill criteria for neurotransmitters. D-serine is an 
example of such “atypical” neurotransmitters. This molecule is synthesized and stored in 
neuroglia and binds to NMDA receptors whose dysregulation has been implicated in the 
pathogenesis of schizophrenia and other psychotic disorders. Other “atypical” 
neurotransmitters that may play significant roles in psychiatric disorders include nitric oxide, 
carbon monoxide, and possibly hydrogen sulfide. It has been suggested that nitric oxide (NO) 
may play an important role in learning and memory.  (Snyder 2000).  
When mental health care is most effective it addresses symptoms of mental illness at their 
root psychological, social, cultural, biological and spiritual causes. The contemporary 
biomedical model of mental health care is limited in its capacity to alleviate the root causes 
of suffering because its theoretical foundations and clinical methods address only some of 
the complex causes and meanings of mental illness. This is largely due to the fact that the 
root causes of mental illness are still poorly understood resulting in numerous poorly 
substantiated models of mental illness causation and a corresponding multiplicity of 
therapies that do not adequately address or correct the root psychological, cultural or 
spiritual meanings or biological causes of symptoms (Wright & Potter 2003). At a basic 
theoretical level the causes of symptom formation in psychiatric illness are poorly 
understood because of the absence of research methods needed to examine and elucidate 
the roles of disparate external and internal factors that cause or exacerbate cognitive, 
affective or behavioral symptoms. This has led to multiple biological and psychodynamic 
theories whose premises are often contradictory or mutually exclusive. In the broader 
context of the history of medicine it is not surprising to find that psychiatry lacks a unifying 
body of theory or universally endorsed standards of clinical practice. Factors contributing to 
the ambiguous position of psychiatry have been discussed at length in two important works 
(Grof 1985; Wilber 2001) Among psychiatrists, the dominant view is an extension of 
contemporary biomedicine, which equates mental health problems to discrete functional 
abnormalities at the level of neurotransmitters. According to this model, successful 
“treatment” entails “correcting” a presumed neurochemical abnormality with the goal of 
restoring to normal a corresponding dysregulation in cognitive, emotional, or behavioral 
functioning. While psychiatrists often use cognitive-behavioral approaches or “talk” 
therapies directed at changing maladaptive interpersonal dynamics, depth psychological 
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approaches examining existential or spiritual themes are typically regarded as incidental to 
“more serious” psychotherapeutic or pharmacological treatments informed by the dominant 
biomedical paradigm. Agreeing on a "most relevant” theory or a “most appropriate” 
treatment is even more problematic for psychologists for whom numerous theories of 
symptom formation have yielded disparate and frequently contradictory explanations of the 
underlying causes or meanings of psychopathology. Because of the multiplicity of theories 
and clinical practices that comprise contemporary psychology and psychiatry there is no 
theory-neutral method for evaluating the relative merits and weaknesses of disparate 
treatments. Subsequently consensus is lacking on the “most appropriate” or “best” 
conceptual framework or practical clinical methods when approaching a specific mental 
health problem. In addressing this dilemma Wilber has systematically reviewed divergent 
psychological theories of mind-body, and has proposed guidelines for the creation of an 
“integral psychology” that takes into account core psychological and spiritual features of 
many dominant theories of mind-body (Wilber 2001). An important practical goal of this 
work is the elaboration of a series of integrative psychotherapeutic strategies that are ideally 
suited for specific symptoms of mind-body, psychological or spiritual distress.   
In a more practical vein contemporary biomedical psychiatry is constrained by ambiguous 
research evidence supporting its various theoretical claims. This stands in contrast to 
biomedicine in general, in which discrete unambiguous relationships have been confirmed 
to take place between identifiable disease-causing factors and discrete disorders. Novel 
assessment and treatment approaches in biomedical psychiatry will emerge from on-going 
advances in the basic neurosciences, brain imaging, immunology and genetics. Future 
models of mental illness causation will not depend exclusively on empirical verification of 
strictly biological processes and will postulate both classically described kinds of biological 
and biophysical causes (eg, genetic factors and neurotransmitter dysregulation) as well as 
non-classical kinds of phenomena (eg, non-linear brain dynamics and quantum-level 
processes). Future studies will used advanced functional imaging technologies to examine 
the role of complex non-linear dynamic relationships between neural circuits and the 
immune system and specific psychiatric disorders, as well as the postulated role of quantum 
“entanglement” associated with large-scale coherent macroscopic quantum field effects in 
both normal consciousness functioning and psychiatric symptom formation.   
5. Important advances are taking place in the theory and practice of 
psychiatry 
In contrast to the limitations of the clinical practice of biomedical psychiatry steady 
advances in medical research are contributing to a more robust paradigm of mental health 
care that will translate into improvements in patient care in the coming decades. On-going 
advances in the neurosciences, psychopharmacology and brain imaging research will soon 
yield novel assessment approaches, more effective and safer conventional treatments 
including drugs based on novel mechanisms of action and new therapeutic uses of light, 
weak electrical current and magnetic fields. Collectively, these advances are transforming 
the theoretical foundations and clinical therapeutics of contemporary Western mental health 
care. Novel theories in biomedical psychiatry promise significant advances in 
understanding of the nature and causes mental illness. For example, it has been suggested 
that non-linear dynamics (ie chaos theory) may help explain mood changes associated with 
the menstrual cycle on the basis of postulated complex influences of hormones and 
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neurotransmitters, as well as social and psychological variables on mood (Rasgon 2003). 
Substantiation of this model by research findings may eventually lead to effective 
preventive strategies addressing hormone-mediated mood disturbances. There is significant 
emerging evidence that complex interactions between immune functioning, 
neurotransmitters and hormones are important in depressed mood, anxiety, and other 
disorders (Miller 2004).  
Improved understanding of genetic factors that mediate mental illness will continue to 
accrue from analysis of the genetic library available in the Human Genome Project. 
Biomedical psychiatric research is increasingly taking into account the significance of 
genetic and biochemical variability in mental illness. For example, the high degree of 
individual variability in response to conventional drugs suggests poorly characterized 
differences in neurotransmitter deficiencies or imbalances associated with major depressive 
disorder, generalized anxiety and other psychiatric disorders (Delgado 2000). Studies on the 
effects of neurotransmitter depletion on mood are consistent with the view that changes in 
brain serotonin or norepinephrine activity levels alone do not fully explain the causes of 
depressed mood or observed differential responses to antidepressants which are probably 
related to complex biological and social factors including genetic variability (and thus 
ethnicity), diet, and culturally determined expectations. Genetic, cultural and social 
variability translates into differences in effective dosing strategies using conventional drugs 
and commensurate differences in susceptibility to adverse effects (Lin 2004). The high 
degree of biological variability may be especially problematic for patients of African or 
Asian ethnicity potentially causing safety issues or poor outcomes (Lawson 2004; Edmond 
2004). The AmpliChip CYP450™ test, recently introduced by Roche Pharmaceuticals, 
incorporates two DNA amplification and detection technologies that screen for genetic 
mutations. The polymerase chain reaction (PCR) is used to amplify or make copies of 
genetic material, and a high-density microarray technology is subsequently used to capture 
and scan the amplified DNA. The device will enable physicians to determine when 
variations or mutations are present in the CYP450 cytochrome system providing clinically 
relevant information about individual differences in prescription drug metabolism. In the 
near future psychiatrists will routinely order outpatient laboratory studies using this 
technology to determine the most appropriate drugs and doses to use for a given patient 
while minimizing the risk of adverse effects (Amanda, Meyers and Nemeroff 2010).  
In biomedical psychiatry classically established forms of energy are used as probes to 
provide information about brain activity associated with symptoms. Normal brain 
functioning is characterized by complex bio-magnetic and electrical activity that can be 
measured using functional brain imaging techniques including positron emission 
tomography (PET), single photon emission computed tomography (SPECT), functional 
magnetic resonance imaging (fMRI), magneto-electroencephalography (MEEG) and 
quantitative electroencephalography (QEEG). Advances taking place in functional brain 
imaging will permit studies on discrete neurotransmitter/receptor systems underlying 
normal conscious functioning as well neural and molecular processes involved in the 
pathogenesis of specific psychiatric disorders. This will result in improved diagnostic 
accuracy of neurologic and psychiatric disorders with commensurate improvements in the 
efficacy of treatments targeting discrete neurotransmitter systems and neural circuits 
(Bandettini 2009). Emerging evidence suggests that consistent relationships exist between 
specific patterns of electrical brain activity and discrete psychiatric disorders (John 2007; 
Bares 2007; Venneman 2006; Brinkmeyer 2004) however it is often difficult to determine 
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whether energetic “abnormalities” in the CNS are causes or effects of pathology. Electrical 
currents and pulsed electromagnetic fields are established conventional treatments in 
contemporary biomedical psychiatry. Electrical current and focused magnetic fields 
probably have real-time effects on the biomagnetic properties of brain functioning in 
addition to long-term effects at the level of neurochemical and biomagnetic changes in the 
activity of brain circuits associated with the regulation of affect, cognition and behavior 
(Liboff 2004).  
Important technological innovations that will become more widely used treatments of 
mental illness in the first half of the 21st century include transcranial magnetic stimulation 
(TMS), EEG biofeedback and virtual reality exposure therapy (VRGET). Biofeedback 
techniques addressed at modifying autonomic activity include galvanic skin resistance 
(GSR), electromyography (EMG), and electroencephalography (EEG) training techniques are 
widely used in outpatient clinic settings to treat phobias and other anxiety disorders. 
Emerging findings suggest that biofeedback training based on heart rate variability (HRV) 
significantly reduces stress and improves general feelings of emotional well-being in 
individuals who are subjected to acute job-related stress (McCraty 2001). Continued rapid 
growth in broad-band internet access will soon result in widespread use of these 
biofeedback techniques by patients at home and at work environments using portable 
devices based on existing computer technology. Chronically anxious patients, and especially 
those with panic disorder or agoraphobia, are frequently too impaired by their symptoms to 
seek professional care. Others are geographically isolated and cannot obtain conventional 
cognitive-behavioral therapy (CBT) or pharmacological treatment for severe anxiety 
syndromes. Broad-band videoconferencing using internet technology is being explored as a 
cost-effective alternative mode of treatment delivery to these home-bound patients. It has 
been established that an effective therapeutic alliance can be achieved between therapist and 
patient when CBT is done by videoconference (Manchanda 1998; Bouchard 2000). Although 
CBT can be done by telephone (telepsychiatry), videoconferencing has the advantage of 
permitting the therapist to demonstrate behavioral exercises to the patient, and both 
therapist and patient are able to accurately observe non-verbal behaviors during sessions 
creating an authentic sense of “presence” that simulates face-to-face interactions in 
conventional psychotherapy settings. A large controlled study showed that CBT is equally 
effective for a range of anxiety symptoms when done in conventional out-patient therapy 
settings or via broad-band videoconferencing (Day 2002). CBT delivered via 
videoconferencing is as effective as face-to-face CBT in patients with both panic disorder 
and agoraphobia (Bouchard 2004). This is a significant finding in that it provides a viable 
and affordable alternative to routine CBT for this severely impaired population who might 
otherwise not utilize mental health services. In the coming decades advances in artificial 
intelligence will lead to the creation of therapist “avatars” that will interact with patients in 
virtual environments, will be capable of optimizing psychotherapeutic interventions in 
response to each unique patient’s needs, and will be capable of simulating both expert 
factual knowledge and therapeutic interventions.  
Controlled studies confirm that virtual reality graded exposure therapy (VRGET) 
(sometimes called experiential cognitive therapy or “ECT” in European countries) is more 
effective than conventional imaginal exposure therapy (using mental imagery to provoke 
the feared object or situation), and is comparable to in vivo exposure therapy (Pertaub 2001; 
Emmelkamp 2001). Many VRGET tools are already available over the internet, permitting 
mental health professionals to guide patients in the use of these computer-based advanced 
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exposure protocols through real-time videoconferencing anywhere high-speed internet 
access is available (Botella 2000). Within the next few decades treatments of phobias, panic 
attacks, and other severe anxiety disorders will combine VRGET with biofeedback, 
cognitive-behavioral therapy (CBT) or mind-body practices in outpatient settings or in the 
patient’s home via real-time interactions permitting authentic “presence” between the 
patient and the therapist or a therapist “avatar” via broadband internet connections. 
Research progress in all of these technology-based therapies will soon yield effective, safe 
non-pharmacological treatments for major depressive disorder, bipolar disorder, anxiety 
disorders and other serious psychiatric disorders. 
Brain-computer interface (BCI) is a frontier technology that is emerging from the new field 
of neural engineering that will soon enable paralyzed individuals to regain use of their 
limbs. This technology permits direct communication between brain centers that control 
movement and robotized prosthetic devices. In the coming decades continued evolution of 
this technology will lead to neuroprosthetic devices that will permit individuals diagnosed 
with psychiatric disorders to regulate behaviors, mood or cognitive problems to enhance 
functioning in all of these areas (Krusianski 2011). By the year 2050 non-invasive 
neuroprosthetic devices will be widely used to effectively and safely treat serious 
psychiatric disorders that are poorly responsive to psychotropic drugs including bipolar 
disorder, severe depressed mood and dementia.  
In addition to advances in psychoparmacology, genetics and technology-based therapies, 
natural product research is yielding significant findings of beneficial effects when a specific 
vitamin, mineral or herbal is used as a monotherapy to treat a specific psychiatric disorder 
(Sarris et al., 2009). An important trend that is pushing the evolution of contemporary 
biomedical psychiatry toward increasing integration with other healing traditions comes 
from the use of synergistic combinations of synthetic drugs and select natural products 
(Sarris et al., 2009). This principle has been demonstrated in many studies showing 
increased antidepressant efficacy when SAMe, folic acid, L-tryptophan or omega-3 fatty 
acids are combined with antidepressants in the treatment of depressed patients. (Sarris et al., 
2009); and increased efficacy when n-acetyl cysteine, magnesium, folic acid or amino acids 
are combined with conventional mood stabilizers in bipolar patients (Sarris et al., 2010b). 
Future studies will examine such synergistic combinations of synthetic drugs and natural 
products to determine optimal formulas addressing common psychiatric disorders. The use 
of natural products including nutrients or botanicals in combination with 
pharmacotherapeutic agents holds the potential for improving outcomes while reducing 
adverse effects by permitting reductions in effective doses of psychotropics and 
commensurate reduction of adverse effect risks.  
6. Novel paradigms are shaping the future of medicine and mental health 
care 
In conventional biomedicine, mainstream concepts from chemistry and biology provide the 
theoretical foundations for current explanatory models of illness phenomena. Conventional 
biomedicine posits that health and illness can be adequately characterized in terms of 
established theories in biology and physics. Some novel approaches in medicine and 
psychiatry do not radically depart from assumptions embedded in the orthodox views of 
conventional biomedicine. For example psychoneuroimmunology (PNI) is a synthetic model 
that starts from established theories in psychiatry and biomedicine and postulates complex 
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dynamic relationships between stress, immunological status and psychiatric or neurological 
symptom formation (Irwin 2008; Muller & Schwarz 2007; Muller & Schwarz 2006). There is a 
rich discussion of PNI and other emerging paradigms in the peer-reviewed journal literature 
including emerging models in physics, biology and information science describing 
structure-function relationships in complex living systems. However, in general the day to 
day clinical practice of biomedicine takes place without regard to these novel ideas. Non-
classical paradigms including complexity theory and quantum field theory (QFT) may 
eventually lead to novel research methodologies that will elucidate subtle inter-relationships 
between “healing intention,” immune status and psychiatric symptom formation. 
Phenomena regarded as legitimate subjects of inquiry in non-Western healing traditions 
have been largely ignored in biomedical research including, for example, the role of prayer 
and intention in health and healing; and putative beneficial effects of so-called “subtle 
energy” on immunological or neurobiological functioning as postulated by practitioners of 
QiGong, “healing touch” or other forms of “energy medicine.”  
Although many non-allopathic therapies meet conventional scientific criteria for efficacy 
and effectiveness they have not been endorsed as mainstream treatments largely because of 
entrenched conservative beliefs in Western medicine and strong academic biases against 
novel ways of understanding illness. Non-allopathic treatments based on biological 
mechanisms of action have been more thoroughly investigated in controlled studies 
compared to mind-body or “energy” therapies. St. John’s Wort (Hypericum perforatum), 
SAMe, 5-HTP and folic acid are examples of non-conventional biological modalities that 
have been thoroughly evaluated. Mind-body therapies and treatments based on established 
or postulated forms of energy or information have not yet been carefully evaluated in 
Western-style research studies. For example, Reiki, qigong, and homeopathy are based on 
postulated forms of energy or information that have not been verified and may in fact not be 
potentially verifiable by Western science. While some non-allopathic therapies are probably 
no more effective than placebos, the same argument can be applied to conventional 
biomedical treatments. The placebo effect is widely accepted among conventional Western 
medical practitioners as playing a significant treatment role in both medical and mental 
health problems (Dixon 2000). Meta-analyses of controlled trials suggest that conventional 
drugs used to treat major depression and other psychiatric disorders are no more effective 
than placebos (Kirsch 2002; Thase 2002; Sussman 2004). Unanswered questions about the 
role of placebo effects in treatment response are shared concerns for both conventionally 
trained and alternative medical practitioners. The controversy over placebo effects is 
complicated by the more recently described “nocebo” effects—adverse effects associated 
with placebos—which may affect as many as 40% of individuals who take placebos 
(Tangrea 1994). These findings suggest that many treatments probably have non-specific 
effects that are either beneficial or detrimental to health, including general effects on the 
body’s immune, endocrinologic, and central nervous system. There is no agreed on theory 
that fully explains placebo and nocebo effects however personal, social and cultural factors 
that are difficult to quanitfy may facilitate “self-healing” when patients undergo any kind of 
medical or psychiatric treatment.  
Disparate systems of medicine postulate the existence and involvement of different forms of 
energy and information in health, illness and healing. Some assessment approaches rely on 
the accurate characterization of classically described biological, energetic or informational 
processes that constitute the presumed causes of a particular symptom or symptom pattern. 
A more complete and accurate understanding of the role of consciousness in health and 
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healing may require a convergence of biomedicine and non-biomedical paradigms. Some 
non-allopathic treatment approaches are based on classical forms of energy including 
electromagnetic energy and sound. Examples include Western herbal medicine, functional 
medicine, EEG biofeedback, music and patterned binaural sounds, full spectrum bright light 
exposure, micro-current brain stimulation, and dim light exposure at selected narrow 
wavelengths. It has been established for decades that all living organisms emit ultra-weak 
photons and under certain conditions such biophotons are emitted as highly ordered or 
“coherent” light (Bajpai 2003; Popp 2003). Research on biophoton emissions from the human 
body have led to speculation about “light channels” that regulate energy and information 
transfer within the body, biological rhythms associated with the intensity and patterns of 
biophoton emissions, and diseases related to energetic “asymmetries” between the left and 
right sides of the body (Cohen 2003; Wijk 2005). Studies on biophoton emissions associated 
with acupoints suggest that subtle differences in count, wavelength and coherence may 
correspond to energetic “imbalances” in yin and yang elements that, according to Chinese 
medical theory, are associated with neurologic and psychiatric disorders (Yang 2004).  
Treatment approaches based on classically accepted forms of energy can have both direct 
energetic effects and indirect informational effects on biological or energetic processes 
associated with health and illnesses. The latter can be described as “informational” effects of 
classical forms of energy. In contrast treatments based on postulated non-classical models of 
energy or information, including quantum mechanics, quantum information, and quantum 
field theory may have both direct and subtle effects on brain functioning and physiology 
(Curtis 2004; Hankey 2004). Functional medicine is an important emerging paradigm that 
views health and illness in relationship to informational changes in complex intercellular 
communication processes. Functional medicine rests on conventional biomedical 
understandings of pathophysiology in the context of assumptions of biochemical and 
genetic individuality (Bland 1999). According to this model health and illness result from 
interactions between the unique genetic constitution of each individual and many different 
internal and external factors including infection, trauma, lifestyle, diet or environmental 
influences that can modify genetic expression and alter intercellular communication 
manifesting as complex physical or psychiatric symptom patterns. Disparate molecules 
serve as cellular mediators, including neuropeptides, steroids, inflammatory mediators and 
neurotransmitters. Functional assessment approaches identify informational changes in 
intercellular communication associated with symptoms, and effective treatments modify the 
informational basis of illness taking into account complex interactions between mediators 
and different cell types. Preliminary findings suggest that immunological dysregulation 
plays a significant causative role in the pathogenesis of affective disorders, schizophrenia, 
Alzheimer disease, and other degenerative neurological disorders (Sperner-Untewegger 
2005). The relationship between immunity and mental illness is complex and poorly 
understood and the same immunological dysregulation is sometimes found in patients with 
disparate symptoms (Irwin 2008). Recent studies suggest that nonspecific over-activation of 
the immune system involving T-helper cells takes place in subgroups of persons with 
schizophrenia (Strous & Shoenfeld 2006). The immune-mediated dysregulation of both 
dopamine and glutamate neurotransmission has also been implicated in the pathogenesis of 
schizophrenia (Muller & Schwarz 2006). In response to these findings, anti-inflammatory 
and immune-modulating therapies are being investigated as future treatments for affective 
disorders and schizophrenia. Horrobin (Horrobin 1996; Horrobin 1998) proposed a 
“membrane phospholipid” model of schizophrenia which posits that abnormal metabolism 
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of phospholipids resulting from genetic and environmental factors manifests as a chronic, 
severe constellation of symptoms typically diagnosed as a variant of schizophrenia or 
schizoaffective disorder. The membrane phospholipid hypothesis posits that a spectrum of 
psychiatric disorders is associated with abnormalities in neuronal membranes and the type 
and severity of symptoms are functions of the magnitude and specific type of metabolic 
errors resulting in abnormal phospholipid metabolism. 
Some established and emerging non-allopathic assessment approaches postulate that illness 
phenomena can be more completely described in terms of non-classical forms of energy. 
Examples include analysis of the vascular autonomic signal (VAS) (Ackerman 2001), Chinese 
meridian diagnosis (Hammer 2001; Zhang 2002; Langevin et al 2004), homeopathic 
constitutional assessment, and Gas Discharge Visualization (GDV) (Korotkov, Williams and 
Wisneski 2004). Because disparate factors contribute to mental illness it is often difficult to 
accurately and reliably assess the causes of symptoms and to identify the most efficacious 
treatments. The integrative mental health care of the future will include sophisticated 
assessment approaches capable of evaluating the causes of mental illness at biological, 
informational and “energetic” levels of body-brain-mind. On-going research studies of non-
allopathic assessment approaches will validate some as clinically useful in mental health care 
while others will become marginalized. The increasing use of novel assessment approaches in 
clinical psychiatry will gradually lead to more comprehensive and more cost-effective 
treatment planning. Promising emerging approaches in psychiatric assessment include: 
 Testing of the urine and blood to reveal dysregulation at the level of neurotransmitters 
and immune factors associated with mental illness  
 Quantitative electroencephalography (QEEG) to quantify differences in brain electrical 
activity for clarifying psychiatric diagnosis and predicting treatment response 
 The use of micro-array “chips” to analyze genetic differences in drug metabolism 
associated with individual differences in the P450 cytochrome system 
 The use of advanced semiconductor devices to measure ultra-weak biophotons 
providing clinically useful indicators of the causes of mental illness at subtle 
neurochemical and“energetic” levels of brain function  
 The use of pulse diagnosis as used in Chinese medicine, Ayurveda, and Tibetan 
medicine and scientific studies to validate energy assessment in the context of novel 
paradigms in physics including quantum mechanics   
Like emerging assessment approaches many non-allopathic treatment approaches are also 
based on postulated non-classical forms of energy or information including for example 
acupuncture, homeopathic remedies, Healing Touch, Qigong and Reiki. In Chinese 
medicine “Qi” is regarded as an elemental energy that cannot be adequately described in the 
language of contemporary science, but may have dynamic attributes that are consistent with 
quantum field theory (Chen 2004). Quantum brain dynamics (QBD) is an example of a non-
classical model which invokes quantum field theory to explain certain dynamic 
characteristics of brain functioning, including possibly the influences of non-classical forms 
of energy or information on mental health. It has been suggested that healing intention 
operates through non-local “subtle” energetic interactions between the consciousness of the 
medical practitioner, and the physical body or consciousness of the patient (Zahourek 2004). 
In contrast, energy psychology assumes that highly developed energetic techniques, 
including acupuncture, acupressure and healing touch, are required to affect energetic 
balance and health. “Mind energetics” is a recently introduced conceptual model that 
postulates the exchange of “energy” through language and intention during therapeutic 
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encounters, and claims that “energy” transforms psychological defenses in beneficial ways 
(Pressman 2004). Widespread interest in the role of spirituality and religion in mental health 
has resulted in increasing research in this area and the inclusion of a special V code in the 
DSM-IV for religious or spiritual problems (Turner 1996).  
7. Complex systems theory will expand the paradigm of biomedical 
psychiatry 
Contemporary biomedical theory argues that medical or psychiatric disorders are 
attributable to discrete “causes” that are biological in nature and take place at the level of 
interactions between molecules or cells. An implicit assumption underlying this reductionist 
view is that for any disorder a particular biological marker corresponds to an underlying 
“cause” in a simple linear fashion. A corollary of this view is that a treatment is “effective” 
when it adequately addresses and ultimately “corrects” the discrete underlying biological 
cause of a specific (medical or psychiatric) symptom or disorder by repairing abnormal 
functioning at a cellular or molecular level. This is in fact the basic logic supporting the 
neurotransmitter theory as an explanatory model in biomedical psychiatry (see above). The 
complex systems model stands in contrast to the conventional view of linear causality that is 
implicit in biomedical theory (Auyang 1998; Bell 2002). Biomedicine is beginning to 
incorporate concepts from emerging theories in physics, biology, and information science 
describing structure-function relationships in complex living systems including the human 
brain. Complex systems theory invites an increasingly integrative perspective in the social 
sciences, biology and medicine. Important advances will take place in the conceptual 
foundations of biomedical psychiatry when the research dialog includes complex systems 
theory, which argues that dynamic non-linear energetic or informational states at multiple 
levels in the brain and body manifest as symptoms (Morowitz & Singer 1995). This view 
implies that although a particular symptom may have one apparent “primary” or discrete 
cause, complex dynamic cause(s) can vary significantly between individuals reporting 
similar symptoms as a consequence of each person’s unique biochemical, genetic, social, 
psychological, and energetic makeup. For example, light exposure therapy is known to have 
therapeutic effects on melatonin and neurotransmitter activity that result in improved 
mood—but emerging research evidence suggests that light interacts with brain dynamics on 
subtle energetic levels consistent with the predictions of quantum mechanics. In contrast to 
the orthodox view of empiricism and linear causality many traditional healing systems 
conceptualize illness, health, and healing in terms of subtle non-linear processes at multiple 
hierarchic levels of body-mind-spirit within each unique human and between humans and 
their environments.  
In the framework of complex systems theory, a symptom or symptom pattern (ie, a 
“disorder”) is viewed as an emergent property of multiple factors interacting at multiple 
hierarchical levels. Practical differences in assessment and treatment approaches in the 
world’s healing traditions can be viewed as reflecting basic differences in assumptions 
underlying contemporary biomedicine and complex systems theory. Biomedicine assumes 
that linear causality operates in the dynamic interactions between natural phenomena and, 
by extension, discrete causal relationships exist between identifiable causal factors and 
disease states in a system that can be adequately characterized using existing empirical 
research methods. In contrast to the linear view, the complex systems model posits that 
dynamic non-linear relationships exist between multiple factors in a hierarchical web and 
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dynamic emergent properties of body-brain-mind experienced as physical or mental 
symptoms (Strogatz 2001). In some cases, for example in the management of infectious 
diseases, discrete symptoms are correlated with an identifiable viral or bacterial infection, 
and the linear biomedical model probably yields a relatively accurate description of 
symptom formation, and is therefore an adequate basis for effective treatment planning. 
However in mental illness, causes, conditions or meanings associated with a symptom 
pattern are typically more complex and change over time. Even in cases where conventional 
biomedical assessment yields clinically useful information, it is reasonable to approach 
assessment of multiple interacting factors associated with mental illness within the 
framework of complex systems theory and to regard discrete biological markers (eg, thyroid 
hormone levels, electrolytes, immune factors) as important elements of a complex dynamic 
web of factors associated with mental illness.  
Conventional biomedicine tacitly acknowledges the validity of the complex systems model 
by employing pharmacological or other kinds of biological treatments targeting disparate 
metabolic or cellular functions when addressing a particular disorder. The same logic 
supports the use of integrative approaches using modalities that combine to yield 
synergistic effects when addressing disparate causal factors underlying psychiatric 
disorders. Although a particular symptom pattern may have one or few primary causes, 
each patient’s unique biochemical, genetic, social, psychological, and possibly also energetic 
or spiritual constitution translates into unique differences at all of these levels in individuals 
diagnosed with the same psychiatric disorder. The situation becomes even more complex 
when taking into account that in any individual the psychological, biological, energetic, 
informational and possibly spiritual causes of a disorder may fluctuate over time in relation 
to both dynamic internal and environmental factors. Conventional biomedical psychiatry 
argues that persisting cognitive, affective and behavioral symptoms in the same individual 
are associated with varying levels of activity in neurotransmitters and receptors—or 
dysfunction at either level—over time however reasons for such variability remain unclear. 
It follows from this observation that an assessment or treatment approach that is 
appropriate for a particular psychiatric disorder at one time for a particular patient may not 
be the most appropriate approach with respect to another individual diagnosed with the 
same disorder, or even the same individual diagnosed with the same disorder at a future 
time. Because complex systems theory does not inform contemporary biomedical psychiatry 
clinical methods used in assessment and treatment planning do not take into account the 
complex and highly variable nature of factors associated mental illness at the level of each 
unique patient. Starting from complex systems theory and assuming that dynamic symptom 
patterns that comprise psychiatric disorders are associated with multiple factors and 
multiple kinds of factors that change over time, it is reasonable to assume that using two or 
more assessment approaches will more adequately capture multiple causes as well as 
different kinds of causes. It follows from the complex systems model that the most 
appropriate and effective treatment plan will include disparate modalities targeting 
disparate causal factors identified through history or formal assessment. Different 
approaches are being used to model complex variables that operate in non-conventional 
healing approaches including path analysis and the analysis of latent variables (Schuck 1997; 
McArcle 2009). The latter approach has been used to assess quality of life in psychotic 
patients (Mercier 1994). 
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8. Emerging understandings of “energy” and information will contribute to 
future mental health care 
Some “alternative” treatments not currently endorsed by biomedical psychiatry are based 
on well described forms of energy such as electromagnetism and sound. Examples include 
EEG biofeedback, music and patterned binaural sounds, full spectrum bright light exposure, 
micro-current brain stimulation, and high-density negative ions. Treatment approaches 
based on such classically described forms of energy and information have specific or general 
beneficial effects at the level of neurotransmitter systems or brain circuits. In contrast, 
treatments based on postulated non-classical kinds of energy or information, including 
quantum mechanics and quantum field theory, may have both direct and subtle effects on 
brain function and mental health. Non-conventional modalities based on concepts that are 
presently outside of the tenets of biomedicine include acupuncture, homeopathic remedies, 
Healing Touch, qigong, and Reiki. Ancient healing traditions and accumulating modern 
research evidence suggest that prayer and other forms of directed intention may help 
alleviate symptoms of physical and mental illness. This is the domain of energy medicine 
(Chen 2004).  
In contrast to the materialist philosophy implicit in contemporary biomedicine and by 
extension biomedical psychiatry, Indo-Asian philosophy is based on the premise that the 
nature of reality, including both inanimate matter and living systems, is best understood in 
terms of fundamental properties of a postulated “vital energy” (Di Stefano, 2006). The 
meaning and role of causality in non-Western systems of medicine is not constrained by 
physical processes interacting in a world ordered by linear time flow. According to this view 
states of both living and non-living systems are regarded as secondary manifestations of 
more primary energetic states. By extension “energetic” factors are believed to play 
important roles in the manifestations of all living systems including changes in functioning 
associated with illness and health. Although “Qi” in Chinese medicine and “Prana” in 
Ayurveda cannot be directly observed or measured using Western style research methods 
professional practitioners of Chinese Medicine and Ayurveda can infer the roles of specific 
energetic “imbalances” when particular illness phenomena are present. Because of the 
philosophical difference between the Western medical tradition and Indo-Asian medicine 
proponents of contemporary biomedicine often regard methods used in non-Western 
systems of medicine as subjective or arbitrary. By the same token, non-Western healing 
traditions often place little emphasis on the empirical methods of Western science that 
attempt to “reduce” subjective symptoms into mechanistic descriptions of discrete 
underlying biological “causes.” Indeed, from the perspectives of traditional Chinese 
medicine (TCM) and Ayurveda, attempts to empirically verify relationships between 
energetic phenomena are regarded as unnecessary because a fundamental energetic 
principle is assumed to be immanent throughout the universe.  
Novel understandings of energy and information are also coming from recent theoretical 
developments in quantum physics. A fundamentally new direction in our understanding of 
consciousness and by extension the causes of mental illness—will come from an emerging 
theory that regards brain functioning from the perspective of quantum mechanics and 
quantum field theory (Naeqau & Kafatos 1999; Elitzur 2005; Lorimer 2004). Quantum brain 
dynamics attempts to explain subtle characteristics of brain functioning in terms of non-
classical forms of energy and information (Jibu and Senta 2001).  Pending further 
confirmation through advanced functional brain imaging studies quantum brain dynamics 
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may eventually help explain reports of therapeutic benefits achieved through non-local 
interactions between the consciousness of the medical practitioner and the patient (Schlitz & 
Braud 1997; Astin 2000; Standish 2001; Wackerman 2003; Standish 2003). This work will 
eventually yield a testable hypothesis about the role of prayer and intention in health and 
healing clarifying therapeutic mechanisms associated with spiritual and mind-body 
practices including meditation, yoga and energy medicine. 
9. Possible future pathways of medicine and psychiatry and a forecast 
Within the first decades of the 21st century psychiatrists will embrace assessment and 
treatment approaches now excluded by orthodox Western medicine. Novel diagnostic and 
treatment modalities will emerge in the context of on-going research on non-conventional 
modalities. Future explanatory models of mental illness will take into account established 
Western scientific theories, emerging paradigms, and non-Western healing traditions. In this 
process Western psychiatry will become a truly integrative paradigm yielding more 
complete understandings of biological, informational and “energetic” processes associated 
with mental illness. A future more integrative psychiatry will emerge from a synthesis of 
disparate explanatory models of mental illness. More complete understandings of complex 
dynamic relationships between biological, somatic, energetic, informational, and possibly 
also spiritual processes associated with symptom formation will lead to more effective 
assessment and treatment approaches addressing causes or meanings of symptoms at 
multiple inter-related hierarchic levels. Future studies on meditation, healing intention, 
meditation and prayer will elucidate the role of consciousness in health and healing.  
It is likely that the theories and methods that comprise conventional biomedicine and 
biomedical psychiatry in the early 21st century will follow one of two possible future 
evolutionary pathways resulting in either continued conservative growth or radical change. 
Although it will not be necessary to go outside the established paradigm of contemporary 
biomedicine in order to develop a conceptual framework for integrative medicine, the 
empirical validation of novel assessment and treatment approaches will require the rigorous 
evaluation of novel concepts in physics, chemistry and biology. This conservative pathway 
does not assume or require the violation of orthodox scientific models of reality based on 
implicit assumptions of linear causal interactions between discrete particles in order to 
explain illness and health. However the conservative model does assume that important 
future directions in medical research will not be completely determined by currently 
entrenched economic, institutional or intellectual dogma influencing beliefs and research 
studies in academic centers. A more radical pathway is conceivable in which an increasingly 
eclectic framework of conventional biomedicine will progressively embrace novel ideas in 
physics and neuroscience as well as concepts from non-conventional systems of medicine 
that rest on assumptions currently outside of the orthodox paradigm (Rubik 1996; Liboff 
2004; Jonas & Crawford 2004). If intellectual, institutional and economic trends favor the 
more radical pathway in the coming decades it is likely that conventional biomedicine—and 
along with it biomedical psychiatry—will gradually transform into a fundamentally new 
paradigm that will have little resemblance to mental health care of the early 21st century. 
Regardless of whether future mental health care undergoes gradual conservative changes or 
radical transformation, practical clinical advances tracking the conceptual evolution of 
medicine will result in an increasingly “whole person” systems approach that will more 
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adequately address the underlying causes and meanings of mental illness. This systems 
approach will incorporate the broad range of both conventional and alternative therapies. 
By employing individually tailored treatments integrative mental health care will will more 
adequately address unique needs and concerns of each patient including their physical and 
psychological well-being, social relationships, and spiritual values. Novel scientific models 
of complex relationships between biological, energetic, and informational processes 
associated with mental illness will lead to more effective integrative assessment and 
treatment strategies addressing the causes or meanings of symptoms at multiple hierarchical 
levels of body-brain-mind. This evolutionary process will result in an increasingly 
integrative perspective in conventional biomedicine and novel explanatory models of illness 
and healing that address the assumptions underlying contemporary Western science and 
medicine. This trend will accelerate in the first half of the 21st century in response to 
increasing intellectual openness in Western culture to non-biomedical systems of medicine 
and ongoing advances in the basic sciences resulting in evolution of the conceptual 
foundations and clinical therapeutics of conventional biomedical psychiatry into a more 
sophisticated model of care incorporating both scientific and intuitive understandings of 
normal psychological functioning and the complex psychological, biological, energetic and 
informational factors contributing to mental illness. 
In the coming decade mental health care will emerge as a more eclectic and more open 
paradigm responding to research advances in both biomedicine and alternative medicine. 
Congressionally mandated reforms will progressively restrict the influence of the 
pharmaceutical industry on research in both academic psychiatry and the private sector. 
Quality manufacturers of select CAM modalities will become established players in an 
increasingly diversified healthcare marketplace in which private insurance and Medicare will 
cover select alternative therapies that will have parity with conventional biomedical 
treatments. Under reforms in health care policy that will come into effect in this decade, 
government, industry and academic research centers will work in a more coordinated fashion 
to develop systematic research programs on a wide range of assessment and treatment 
modalities resulting in more effective and more cost-effective treatment choices addressing 
urgent unmet needs of mental health care in the U.S. and other western countries. Increased 
collaboration between researchers and clinicians in the U.S. and internationally will help 
advance and accelerate evolution towards integrative mental health care. 
The first decades of the 21st century will bring a gradual transition away from 
psychopharmacology as the dominant mode of treatment toward increasing reliance on 
advanced technologies for alleviating serious mental illness. Growing global access to 
broadband internet services will permit patients to benefit from psychotherapy through 
“tele-presence,” advanced biofeedback techniques and virtual reality exposure therapy, and 
therapist “avatars” in the comfort of their homes. By the year 2050 psychiatrists and other 
mental health practitioners will routinely use a scientifically validated integrative “tool kit” 
incorporating the most advanced biomedical technologies together with empirically 
validated traditional healing practices. The more integrative mental health care of the future 
will permit more accurate assessment of biological, energetic and informational factors 
associated with symptoms and lead to individualized multi-level treatment strategies 
addressing the unique pattern of biological, energetic and informational factors associated 
with each patient’s unique symptoms. The transformation of biomedical psychiatry to 
integrative mental health care will result in deeper understandings of mental illness, 
improved and more rapid treatment response, and reduced costs.  
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By mid-century a new paradigm will be solidly established and will inform the theories and 
clinical therapeutics of mental health care. Biomedical theory will be informed by complexity 
theory, novel theories in physics and information science and accumulating findings from the 
basic sciences and consciousness research. There will no longer be a rigid dichotomy between 
biomedical and alternative modalities. By mid-century advances in the genetics and 
neurobiology of mental illness will have yielded more specific, more effective and more 
individualized pharmacological, genetic and energetic therapies for major psychiatric 
disorders. Rigorously designed Western-style research studies will have verified the 
mechanisms of action of some non-conventional biological, mind-body and so-called “energy” 
modalities and validated their therapeutic claims. By the same token many contemporary 
conventional and alternative modalities will have been discredited as lacking efficacy by well 
designed studies and will no longer be used. Treatments that will be abandoned in the coming 
decades will include many conventional pharmacological therapies and psychotherapeutic 
treatments in current widespread use as well as natural products from diverse healing 
traditions. In parallel with these changes on-going advances in functional brain imaging will 
permit studies on postulated roles of magnetic fields, biophotons, and macroscopic highly 
coherent quantum field effects on normal brain functioning and mental illness.  
10. Concluding remarks 
Mental health care as practiced today is in urgent need of new ideas, better, safer, more 
affordable and more compassionate approaches to the prevention and treatment of mental 
illness. The future of mental health care is being shaped by emerging paradigms in the basic 
sciences, increasing openness to non-Western systems of medicine, changing clinicians’ 
attitudes, but most of all by our patients’ demands for better, more personalized and more 
compassionate care.  
The theoretical foundations and clinical practices of mental health care will continue to 
evolve as biomedicine begins to explore perspectives that recognize complex inter-
relationships in brain-body-mind, for example, the field of psychoneuroimmunlogy, an 
integrative paradigm which reconciles non-biomedical systems of medicine with 
contemporary biomedicine has been emerging for some time now and yield significant 
improvements in the day to day practice of mental health care (Irwin 2008). A more robust 
theory of mental illness causation will require novel research methodologies to adequately 
address complex psychological, neurochemical, immunological and energetic mechanisms 
associated with both normal brain functioning and mental illness. The new paradigm that is 
emerging from advances in functional brain imaging, genetics, and molecular biology will 
be capable of elucidating complex relationships between the biological and electromagnetic 
( possibly also quantum-level) activity of the brain and body in healthy individuals, as well 
complex factors underlying cognitive, affective and behavioral symptoms. The new 
paradigm will be highly integrative taking into account both classically described biological 
factors including neurophysiological and immunological functioning as well a non-classical 
phenomena, including the postulated role of macroscopic coherent quantum fields in 
neuronal activity associated with human consciousness (Pizzi 2004; Thaheld 2001). The 
disparate viewpoints of biomedicine and non-Western healing traditions call for conceptual 
bridges between different systems of medicine and practical strategies for integrating 
therapeutics used in different cultures. Future technologies may eventually result in 
empirical validation of “Qi” or other non-Western concepts of “energy” however important 
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differences will probably persist between the theories and clinical practices of biomedicine 
and non-conventional healing traditions. 
11. 
Dr. Lake chairs the International Network of Integrative Mental Health www.INIMH.org 
You may contact Dr. Lake at www.IntegrativeMentalHealth.net. 
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